Treatment of chronically infected wounds is a challenge, and bacterial environmental contamination is a growing issue in infection control. Ozone may have a role in these situations. Fontes, et al. (2012) sought to determine whether a low dose of gaseous ozone/oxygen mixture eliminates pathogenic bacteria cultivated in Petri dishes.
Â
A pilot study with six bacterial strains was conducted using different concentrations of ozone in an ozone-oxygen mixture to determine a minimally effective dose that completely eliminated bacterial growth. The small and apparently bactericidal gaseous dose of 20 mug/mL ozone/oxygen (1:99) mixture, applied for 5min under atmospheric pressure was selected. In the 2nd phase, eight bacterial strains with well characterized resistance patterns were evaluated in vitro using agar-blood in adapted Petri dishes (105 bacteria/dish). The cultures were divided into three groups: 1) ozone-oxygen gaseous mixture containing 20 mug of O3/mL for 5 minutes; 2) 100 percent oxygen for 5 minutes; 3) baseline, no gas was used.
Â
The selected ozone dose was applied to the following eight strains: Escherichia coli, oxacillin-resistant Staphylococcus aureus, oxacillin-susceptible Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis, extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, carbapenem-resistant Acinetobacter baumannii, Acinetobacter baumannii susceptible only to carbapenems, and Pseudomonas aeruginosa susceptible to imipenem and meropenem. All isolates were completely inhibited by the ozone-oxygen mixture while growth occurred in the other two groups.
 Â
The researchers concluded that a single topical application by nebulization of a low ozone dose completely inhibited the growth of all potentially pathogenic bacterial strains with known resistance to antimicrobial agents. Their research was published in BMC Infectious Diseases.Â
Reference: Fontes B, et al. Effect of low-dose gaseous ozone on pathogenic bacteria. BMC Infectious Diseases 2012, 12:358 doi:10.1186/1471-2334-12-358
CDC Speaks About New Data From Antimicrobial Resistance Threats Fact Sheet
July 18th 2024In a follow-up to Infection Control Today's (ICT's) article on the CDC's Antimicrobial Resistance Threats in the US 2021-2022 release, Michael Craig, MPP, director of CDC's Antimicrobial Resistance Coordination and Strategy Unit, answers ICT's questions.
An Infection Preventionist Considers Why Manufacturers Need to Update IFUs
July 11th 2024Katharine J. Hoffman, MPH, CIC, LSSGB: It’s time to take the devil out of the details in interpreting and successfully following manufacturers' instructions for use; why do manufacturers need to update IFUs?
The 90’s Club: A Successful Hand Hygiene Adherence Campaign
July 9th 2024The "90’s SwipeSense Club" significantly improved hand hygiene adherence at Novant Health Thomasville Medical Center. By incentivizing adherence through 1990s-themed rewards and using SwipeSense technology to track hygiene practices, the hospital increased adherence rates from 53% in 2021 to 84% by May 2024.